MILAN, ITALY — Amplifon, parent company of Miracle-Ear and a global leader in hearing care services, today announced the appointment of Dr. Nicholas Reed to the newly created role of Vice President of Audiology Innovation and Research.
In this role, Dr. Reed will oversee Amplifon’s research initiatives and support the company’s broader efforts in audiology and hearing health. He joins Amplifon with a background in both audiology and public health, with research focused on the relationship between hearing loss and broader health outcomes.
Focus on research and clinical innovation
Dr. Reed’s work has emphasized the connection between hearing care and population health, including studies examining links between hearing loss, cognitive decline, and overall health. His appointment reflects Amplifon’s continued investment in research and evidence-based approaches to care.
“We are honored to welcome Dr. Nicholas Reed to our team. His reputation as a world-class researcher and his profound knowledge of hearing health make him the ideal person to lead our research initiatives in audiology. His appointment represents a significant investment by Amplifon in the future of hearing care: by integrating Dr. Reed’s expertise in epidemiology and clinical audiology, we will further refine our protocols and make our services even more innovative, personalized, and effective, with the goal of improving the quality of life for millions of people worldwide.”
–Enrico Vita, CEO of Amplifon
Nicholas Reed
Dr. Nicholas Reed, Vice President of Audiology Innovation and Research, added: “I have spent my career striving to ensure that research makes a tangible difference in people’s lives. Joining Amplifon provides a unique global platform to scale that mission. I am excited to support the company’s efforts in health innovation, fostering closer ties with the scientific community to ensure that every individual has access to the highest quality, evidence-based hearing care.”
Dr. Reed will be based at Amplifon Americas’ headquarters in Minneapolis.
Background in audiology and public health
Dr. Reed is recognized for his contributions to audiology and public health research, particularly in advancing understanding of how hearing loss intersects with aging and broader healthcare outcomes. His work has helped inform ongoing discussions around hearing care access, prevention, and long-term health impacts.
About Dr. Nicholas Reed
Dr. Nicholas Reed (AuD, PhD) is an internationally recognized audiology and public health researcher focused on hearing loss, aging, and health care. He has held academic positions at NYU Grossman School of Medicine and Johns Hopkins University, with over 200 publications and major research contributions linking hearing loss to cognitive decline and health outcomes.
About Amplifon
Amplifon, global leader in the retail hearing care market, makes it possible to rediscover all the emotions of sound. All of Amplifon’s around 20,600 employees worldwide are committed to understanding the unique needs of each customer, offering exclusive, innovative, and highly personalized products and services to ensure the best solution for everyone. The Group, with annual revenues of approximately €2.4 billion (~$2.6 billion USD), operates through a network of around 10,000 locations in 25 countries and 5 continents. For more information about the Group: https://corporate.amplifon.com
Source: Amplifon
